Vision treatment strategy for acute blindness in adolescent female with diffuse leptomeningeal glioneuronal tumor | Canada Hyperbarics Skip to main content
Case Report Int J Neurosci 2020

Vision treatment strategy for acute blindness in adolescent female with diffuse leptomeningeal glioneuronal tumor

Zhou S, Zhang M, Wu H, Liu G, Wang Y, Bao Y — Int J Neurosci, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the case of an adolescent female who regained her vision after emergency surgery and a combination of treatments, including hyperbaric oxygen, for acute blindness caused by a rare brain tumour.

What They Found

The patient, who had acute rapid blindness in both eyes due to a diffuse leptomeningeal glioneuronal tumour, saw her vision return to normal after receiving emergency Ommaya sac drainage surgery and a comprehensive treatment plan. This plan included Edaravone, Alprostadil, Monosialotetrahexosylganglioside, Butylphthalide, hyperbaric oxygen, and acupoint injection of Anisodine.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report involving multiple treatments, it is not possible to determine the specific effect of hyperbaric oxygen therapy alone or generalize these findings to other patients.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Ocular / Retinal
Source Pubmed
PubMed ID 32067532
Year Published 2020
Journal Int J Neurosci
MeSH Terms Adolescent; Benzofurans; Blindness; Cerebrospinal Fluid Shunts; Female; Humans; Meningeal Neoplasms; Neuroprotective Agents

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology